Supporting Type 1 Diabetes with a Functional-Medicine Approach

by

We interviewed Carla Atherton, Director of the Healthy Family Formula, about supporting type 1 diabetes with a functional-medicine approach. You can watch the replay below. Please note that you will be asked to enter your email address at the 30-minute mark to finish viewing the video.


Carla’s Story

Carla Atherton’s daughter developed type 1 diabetes seven years ago. She discovered that mainstream medicine’s main way of dealing with type 1 diabetes is matching insulin to carbohydrates. Surely there must be more to it than that? And what causes or contributes to it?

Instead of thinking, “that’s all there is to it”, she dove into functional medicine, an individualized, patient-centered, science-based approach that looks to eliminate rather than suppress symptoms by looking at the root causes of a disease or condition.

In This Webinar

Carla explained to us how, through functional medicine practices and testing, you can potentially be supporting type 1 diabetes by:

  • Find the root causes of your child’s diabetes
  • Reduce or eliminate risk of further disease progression and complications
  • Reduce or eliminate risk of developing co-morbidities
  • Have a better relationship with your healthcare practitioners and chose the ones that will work with you in a manner that works for you
  • Optimize your child’s health through your own efforts
  • Explore the possibility of complete disease reversal or elimination of symptoms

About Carla Atherton MA FDN-P

Carla Atherton, MA, FDN-P, Family Health Coach, is the director of The Healthy Family Formula, host of The Children’s and Teen Health Summit, author of Family Health Revolution, editor, book junkie and research geek.  She is the insatiably curious mother of three grown (son age 20), almost grown (daughter age 18), and growing (daughter age 15) children, one of whom has type 1 diabetes.

Carla lives on an acreage in rural Saskatchewan, Canada, where she works from a home office with families from all over the world on the reversal of children’s chronic health conditions. Carla is on a revolutionary mission to empower families to transcend our new normal of ill health and chronic disease. You can find out more about her and her work at her website https://healthyfamilyformula.com/

Carla Atherton

Disclaimer

This webinar is not a substitute for medical advice, treatment, diagnosis, or consultation with a medical professional. It is intended for general informational purposes only and should not be relied on to make determinations related to treatment of a medical condition. Epidemic Answers has not verified and does not guaranty the accuracy of the information provided in this webinar.

Still Looking for Answers?

Visit the Epidemic Answers Practitioner Directory to find a practitioner near you.

Join us inside our online membership community for parents, Healing Together, where you’ll find even more healing resources, expert guidance, and a community to support you every step of your child’s healing journey.

Sources & References

Accurso, A., et al. Dietary carbohydrate restriction in type 2 diabetes mellitus and metabolic syndrome: time for a critical appraisal. Nutr Metab (Lond). 2008 Apr 8:5:9.

Adebayo, O., et al. The changing face of diabetes in America. Emerg Med Clin North Am. 2014;32(2):319-27.

Bahr, L.S., et al. Ketogenic diet and fasting diet as Nutritional Approaches in Multiple Sclerosis (NAMS): protocol of a randomized controlled study. Trials. 2020 Jan 2;21(1):3.

Banerjee, S., et al. Ayurveda in changing scenario of diabetes management for developing safe and effective treatment choices for the future. J Complement Integr Med. 2015.

Bernstein, R.K. Blood glucose self-monitoring by diabetic patients: refinements of procedural technique. Diabetes Care. 1979 Mar-Apr;2(2):233-6.

Bernstein, R.K. Virtually continuous euglycemia for 5 yr in a labile juvenile-onset diabetic patient under noninvasive closed-loop control. Diabetes Care. 1980 Jan-Feb;3(1):140-3.

Bradford, B.L., et al. Mitochondrial Dysfunction and Type 2 Diabetes. Science. 2005 Jan 21;307(5708):384-7.

Brenton, J.N., et al. Phase II study of ketogenic diets in relapsing multiple sclerosis: safety, tolerability and potential clinical benefits. J Neurol Neurosurg Psychiatry. 2022 Jun;93(6):637-644.

Brenton, J.N., et al. Pilot study of a ketogenic diet in relapsing-remitting MS. Neurol Neuroimmunol Neuroinflamm. 2019 Apr 12;6(4):e565.

Choquet, H., et al. Genomic insights into early-onset obesity. Genome Med. 2010;2(6):36.

Classen, J.B. Review of evidence that epidemics of type 1 diabetes and type 2 diabetes/metabolic syndrome are polar opposite responses to iatrogenic inflammation. Curr Diabetes Rev. 2012;8(6):413-8.

Dietch, D.M., et al. Efficacy of low carbohydrate and ketogenic diets in treating mood and anxiety disorders: systematic review and implications for clinical practice. BJPsych Open. 2023 Apr 17;9(3):e70.

Feinman, R.K., et al. Dietary carbohydrate restriction as the first approach in diabetes management: critical review and evidence base. Nutrition. 2015 Jan;31(1):1-13.

Hinzmann, R., et al. What do we need beyond hemoglobin A1c to get the complete picture of glycemia in people with diabetes? Int J Med Sci. 2012;9(8):665-81.

Laron, Z. Interplay between heredity and environment in the recent explosion of type 1 childhood diabetes mellitus. Am J Med Genet. 2002;115(1):4-7.

Karkafi, R.E., et al. Ketogenic Diet and Inflammation: Implications for Mood and Anxiety Disorders. Adv Exp Med Biol. 2023:1411:537-554.

Laron, Z. Interplay between heredity and environment in the recent explosion of type 1 childhood diabetes mellitus. Am J Med Genet. 2002;115(1):4-7.

Lennerz, B.S., et al. Management of Type 1 Diabetes With a Very Low-Carbohydrate Diet.
Pediatrics. 2018 Jun;141(6):e20173349.

Power, R.A., et al. Carnitine revisited: potential use as adjunctive treatment in diabetes. Diabetologia. 2007 Apr;50(4):824-32.

Rector, R.S., et al. Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model. J Hepatol. 2010 May;52(5):727-36.

Rosa, J.S., et al. Altered inflammatory, oxidative, and metabolic responses to exercise in pediatric obesity and type 1 diabetes. Pediatr Diabetes. 2011;12(5):464-72.

Smith, J., et al. Ketogenic diet restores aberrant cortical motor maps and excitation-to-inhibition imbalance in the BTBR mouse model of autism spectrum disorder. Behav Brain Res. 2016 May 1:304:67-70.

Vaarala, O. Is the origin of type 1 diabetes in the gut? Immunol Cell Biol. 2012;90(3):271-6.

Vaarala, O. Gut microbiota and type 1 diabetes. Rev Diabet Stud. 2012;9(4):251-9.

Yuan, J., et al. Regular use of proton pump inhibitors and risk of type 2 diabetes: results from three prospective cohort studies.

Back to webinars